ApprovalTrail

Approval · Notice of Compliance 22381 · 2019

ETIBI: Notice of Compliance 22381

Issued July 10, 2019

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
22381
Date
July 10, 2019
Company
Bausch Health, Canada Inc.Laval, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Administrative: Change in Product Ownership

Products in this notice

BrandDINStatus today
ETIBI00247960Marketed
ETIBI00247979Marketed

Medicinal ingredients